Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial. Read more about Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A. Read more about Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A.
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Read more about Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
HLA-independent T cell receptors for targeting tumors with low antigen density. Read more about HLA-independent T cell receptors for targeting tumors with low antigen density.
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial. Read more about Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.
AI as a new paradigm for risk-based screening for breast cancer. Read more about AI as a new paradigm for risk-based screening for breast cancer.
Reporting guidelines for human microbiome research: the STORMS checklist. Read more about Reporting guidelines for human microbiome research: the STORMS checklist.
Mutations and variants of ONECUT1 in diabetes. Read more about Mutations and variants of ONECUT1 in diabetes.
Federated learning for predicting clinical outcomes in patients with COVID-19. Read more about Federated learning for predicting clinical outcomes in patients with COVID-19.
Transcriptional mediators of treatment resistance in lethal prostate cancer. Read more about Transcriptional mediators of treatment resistance in lethal prostate cancer.
